• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties.对精神疾病风险因素FKBP51的药理学抑制具有抗焦虑特性。
J Neurosci. 2015 Jun 17;35(24):9007-16. doi: 10.1523/JNEUROSCI.4024-14.2015.
2
Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis.FKBP51 抑制诱导应激弹性和改变海马神经发生。
Mol Psychiatry. 2022 Dec;27(12):4928-4938. doi: 10.1038/s41380-022-01755-9. Epub 2022 Sep 14.
3
Selective inhibitors of the FK506-binding protein 51 by induced fit.FK506 结合蛋白 51 的诱导契合选择性抑制剂。
Nat Chem Biol. 2015 Jan;11(1):33-7. doi: 10.1038/nchembio.1699. Epub 2014 Dec 1.
4
The prospect of FKBP51 as a drug target.FKBP51 作为药物靶点的前景。
ChemMedChem. 2012 Aug;7(8):1351-9. doi: 10.1002/cmdc.201200137. Epub 2012 May 13.
5
GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors.在大鼠高架十字迷宫焦虑样行为测试中,基底外侧杏仁核内GABA与组胺的相互作用
Pharmacology. 2008;82(1):59-66. doi: 10.1159/000131110. Epub 2008 May 10.
6
Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs.精神疾病风险因素FKBP51的药理学调节改变常用抗抑郁药物的疗效。
Front Behav Neurosci. 2018 Nov 12;12:262. doi: 10.3389/fnbeh.2018.00262. eCollection 2018.
7
The selective FKBP51 inhibitor SAFit2 reduces alcohol consumption and reinstatement of conditioned alcohol effects in mice.选择性 FKBP51 抑制剂 SAFit2 可减少小鼠的酒精摄入量和条件性酒精效应的复燃。
Addict Biol. 2020 May;25(3):e12758. doi: 10.1111/adb.12758. Epub 2019 Jun 7.
8
Recent Progress in FKBP Ligand Development.FKBP配体开发的最新进展。
Curr Mol Pharmacol. 2015;9(1):27-36. doi: 10.2174/1874467208666150519113313.
9
1,4-Pyrazolyl-Containing SAFit-Analogues are Selective FKBP51 Inhibitors With Improved Ligand Efficiency and Drug-Like Profile.含 1,4-吡唑基的 SAFit 类似物是选择性 FKBP51 抑制剂,具有改善的配体效率和类药性特征。
ChemMedChem. 2024 Sep 2;19(17):e202400264. doi: 10.1002/cmdc.202400264. Epub 2024 Jul 8.
10
Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.大鼠基底外侧杏仁核中 5-HT1A 受体的激活既能诱导抗焦虑作用,也能诱导抗惊恐样作用。
Behav Brain Res. 2013 Jun 1;246:103-10. doi: 10.1016/j.bbr.2013.03.005. Epub 2013 Mar 13.

引用本文的文献

1
FKBP5 Induces Senescence in BMSCs and Inhibits Osteogenic Differentiation Through the Canonical WNT/β-Catenin Signalling Pathway in Senile Osteoporosis.FKBP5通过经典WNT/β-连环蛋白信号通路诱导骨髓间充质干细胞衰老并抑制老年骨质疏松症中的成骨分化。
J Cell Mol Med. 2025 Apr;29(8):e70552. doi: 10.1111/jcmm.70552.
2
FKBP51 in glutamatergic forebrain neurons promotes early life stress inoculation in female mice.谷氨酸能前脑神经元中的FKBP51促进雌性小鼠的早期生活应激接种。
Nat Commun. 2025 Mar 14;16(1):2529. doi: 10.1038/s41467-025-57952-x.
3
Deep phenotyping reveals CRH and FKBP51-dependent behavioral profiles following chronic social stress exposure in male mice.深度表型分析揭示了雄性小鼠在慢性社会应激暴露后依赖促肾上腺皮质激素释放激素(CRH)和FK506结合蛋白51(FKBP51)的行为特征。
Neuropsychopharmacology. 2025 Feb;50(3):556-567. doi: 10.1038/s41386-024-02008-9. Epub 2024 Oct 22.
4
DNA methylation patterns of FKBP5 regulatory regions in brain and blood of humanized mice and humans.人类化小鼠和人类大脑及血液中 FKBP5 调节区域的 DNA 甲基化模式。
Mol Psychiatry. 2024 May;29(5):1510-1520. doi: 10.1038/s41380-024-02430-x. Epub 2024 Feb 5.
5
Knocking out Fkbp51 decreases CCl-induced liver injury through enhancement of mitochondrial function and Parkin activity.敲除Fkbp51可通过增强线粒体功能和帕金蛋白活性减轻四氯化碳诱导的肝损伤。
Cell Biosci. 2024 Jan 2;14(1):1. doi: 10.1186/s13578-023-01184-3.
6
Imbalanced glucocorticoid and mineralocorticoid stress hormone receptor function has sex-dependent and independent regulatory effects in the mouse hippocampus.糖皮质激素和盐皮质激素应激激素受体功能失衡在小鼠海马体中具有性别依赖性和非依赖性调节作用。
Neurobiol Stress. 2023 Nov 17;28:100589. doi: 10.1016/j.ynstr.2023.100589. eCollection 2024 Jan.
7
Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery.FKBP5及其基因突变在应激诱导的精神疾病中的作用:药物发现的机遇
Front Psychiatry. 2023 Jun 16;14:1182345. doi: 10.3389/fpsyt.2023.1182345. eCollection 2023.
8
Sex-specific and opposed effects of FKBP51 in glutamatergic and GABAergic neurons: Implications for stress susceptibility and resilience.性别特异性和 FKBP51 在谷氨酸能和 GABA 能神经元中的相反作用:对压力易感性和弹性的影响。
Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2300722120. doi: 10.1073/pnas.2300722120. Epub 2023 May 30.
9
Intact Recognition Memory and Altered Hippocampal Glucocorticoid Receptor Signaling in Fkbp5-deficient Mice Following Acute Uncontrollable Stress.Fkbp5基因缺陷小鼠在急性不可控应激后完整的识别记忆及海马糖皮质激素受体信号改变
Exp Neurobiol. 2023 Apr 30;32(2):91-101. doi: 10.5607/en23006.
10
Structure and function of the TPR-domain immunophilins FKBP51 and FKBP52 in normal physiology and disease.TPR结构域亲免蛋白FKBP51和FKBP52在正常生理及疾病中的结构与功能
J Cell Biochem. 2024 Dec;125(12):e30406. doi: 10.1002/jcb.30406. Epub 2023 Apr 23.

本文引用的文献

1
Selective inhibitors of the FK506-binding protein 51 by induced fit.FK506 结合蛋白 51 的诱导契合选择性抑制剂。
Nat Chem Biol. 2015 Jan;11(1):33-7. doi: 10.1038/nchembio.1699. Epub 2014 Dec 1.
2
Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume.FKBP5在情绪加工中的作用:杏仁核活动、连接性及体积方面的研究结果
Brain Struct Funct. 2015;220(3):1355-68. doi: 10.1007/s00429-014-0729-5. Epub 2014 Apr 23.
3
Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.FKBP5 基因多态性与重度抑郁症应激激素失调程度相关。
Genes Brain Behav. 2013 Apr;12(3):289-96. doi: 10.1111/gbb.12026. Epub 2013 Mar 7.
4
Towards new approaches to disorders of fear and anxiety.迈向恐惧和焦虑障碍新方法。
Curr Opin Neurobiol. 2013 Jun;23(3):346-52. doi: 10.1016/j.conb.2013.01.013. Epub 2013 Feb 9.
5
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.FKBP5 基因变异:与选择性 5-羟色胺再摄取抑制剂治疗重度抑郁症的疗效的相关性。
Pharmacogenet Genomics. 2013 Mar;23(3):156-66. doi: 10.1097/FPC.0b013e32835dc133.
6
Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims.自杀者杏仁核中 FKBP5 和糖皮质激素受体的基因和蛋白改变。
Psychoneuroendocrinology. 2013 Aug;38(8):1251-8. doi: 10.1016/j.psyneuen.2012.11.008. Epub 2012 Dec 5.
7
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions.等位基因特异性 FKBP5 DNA 去甲基化介导基因-儿童期创伤的相互作用。
Nat Neurosci. 2013 Jan;16(1):33-41. doi: 10.1038/nn.3275. Epub 2012 Dec 2.
8
Fkbp52 heterozygosity alters behavioral, endocrine and neurogenetic parameters under basal and chronic stress conditions in mice.FKBP52 杂合性改变了小鼠在基础和慢性应激条件下的行为、内分泌和神经发生参数。
Psychoneuroendocrinology. 2012 Dec;37(12):2009-21. doi: 10.1016/j.psyneuen.2012.04.017. Epub 2012 May 27.
9
The prospect of FKBP51 as a drug target.FKBP51 作为药物靶点的前景。
ChemMedChem. 2012 Aug;7(8):1351-9. doi: 10.1002/cmdc.201200137. Epub 2012 May 13.
10
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.评估合成 FK506 类似物作为 FK506 结合蛋白 51 和 52 的配体。
J Med Chem. 2012 May 10;55(9):4114-22. doi: 10.1021/jm201746x. Epub 2012 Apr 19.

对精神疾病风险因素FKBP51的药理学抑制具有抗焦虑特性。

Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties.

作者信息

Hartmann Jakob, Wagner Klaus V, Gaali Steffen, Kirschner Alexander, Kozany Christian, Rühter Gerd, Dedic Nina, Häusl Alexander S, Hoeijmakers Lianne, Westerholz Sören, Namendorf Christian, Gerlach Tamara, Uhr Manfred, Chen Alon, Deussing Jan M, Holsboer Florian, Hausch Felix, Schmidt Mathias V

机构信息

Max Planck Institute of Psychiatry, 80804 Munich, Germany, and

Max Planck Institute of Psychiatry, 80804 Munich, Germany, and.

出版信息

J Neurosci. 2015 Jun 17;35(24):9007-16. doi: 10.1523/JNEUROSCI.4024-14.2015.

DOI:10.1523/JNEUROSCI.4024-14.2015
PMID:26085626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6605153/
Abstract

Anxiety-related psychiatric disorders represent one of the largest health burdens worldwide. Single nucleotide polymorphisms of the FK506 binding protein 51 (FKBP51) gene have been repeatedly associated with anxiety-related disorders and stress sensitivity. Given the intimate relationship of stress and anxiety, we hypothesized that amygdala FKBP51 may mediate anxiety-related behaviors. Mimicking the stress effect by specifically overexpressing FKBP51 in the basolateral amygdala (BLA) or central amygdala resulted in increased anxiety-related behavior, respectively. In contrast, application of a highly selective FKBP51 point mutant antagonist, following FKBP51(mut) BLA-overexpression, reduced the anxiogenic phenotype. We subsequently tested a novel FKBP51 antagonist, SAFit2, in wild-type mice via BLA microinjections, which reduced anxiety-related behavior. Remarkably, the same effect was observed following peripheral administration of SAFit2. To our knowledge, this is the first in vivo study using a specific FKBP51 antagonist, thereby unraveling the role of FKBP51 and its potential as a novel drug target for the improved treatment of anxiety-related disorders.

摘要

焦虑相关的精神障碍是全球最大的健康负担之一。FK506结合蛋白51(FKBP51)基因的单核苷酸多态性 repeatedly 与焦虑相关障碍和应激敏感性有关。鉴于应激与焦虑的密切关系,我们推测杏仁核FKBP51可能介导焦虑相关行为。通过在基底外侧杏仁核(BLA)或中央杏仁核中特异性过表达FKBP51来模拟应激效应,分别导致焦虑相关行为增加。相比之下,在FKBP51(mut)BLA过表达后应用高度选择性的FKBP51点突变拮抗剂,可减轻致焦虑表型。我们随后通过BLA微量注射在野生型小鼠中测试了一种新型FKBP51拮抗剂SAFit2,它可减轻焦虑相关行为。值得注意的是,在SAFit2外周给药后也观察到了相同的效果。据我们所知,这是第一项使用特异性FKBP51拮抗剂的体内研究,从而揭示了FKBP51的作用及其作为改善焦虑相关障碍治疗的新型药物靶点的潜力。